I was fortunate enough to attend the South By SouthWest Interactive conference (colloquially ‘Southby’ or SXSW), which benefited from a health ‘track’ that focused on innovation and digital in healthcare. At the event, I attended a number of panels and I would like to share my notes on some of the panels here. So, I […]Read More SXSW feature: The secret life of behaviour change
Last week I predicted Apple would drop the price of the iPad for the launch of the iPad 2. Looks like I was right, as Apple have announced a £100 reduction in the price of the original iPad in the UK, with other countries receiving similar reductions. Whether this is for clearing stock of the […]Read More Right about Xoom and iPad 2
I was pretty excited about the announcements before and during the Mobile World Congress in Barcelona last week. Android was the star of the show, with many many manufacturers showing off hardware that uses the operating system. Forefront in the hype was the tablet-specific iteration, called Honeycomb that will be available on many of the […]Read More Motorola Xooms itself in the foot?
I love the idea that you could fire up an app on your smartphone and check your health records, or if you are a physician, you can peruse the drug interactions for HIV medications on your iPhone. the healthcare ‘mobile revolution’ appears to be starting, and mobile healthcare is predicted to be very big starting […]Read More Will bandwidth capping/throttling scupper Mhealth?
A quick apology to readers of this blog. I really enjoy writing here, but the past month has thrown up a number of challenges. One of these challenges is actually finding something interesting and, importantly, new, to write about. There are so many bloggers out there that I feel I would be doing you a […]Read More Balloon animals
I probably don’t need to tell you that there has been buzz recently about the new FDA guidance on social media that is predicted to appear in this year Indeed, John Mack predicted that the guidance would be issued in sections, and he puts forward a theory that guidance on short-format or space-limited communications will […]Read More Social media sharing for pharma
I want to pick up a bit more on the closing remark from my DigiPharm Europe 2010 posts. If you recall, I said: To survive in this landscape, Pharma must make inroads into developing a digital strategy – and by that I mean integrate your digital tactics into your overall strategic plan, and at the […]Read More When is digital strategy not digital strategy?
Here’s my final post on the #DigiPharm narrative. Part 7! Again, I am reporting on selected sessions from Day 2, ones that I found of note or interest. You can read the twitterstream for more information on the presentations not covered here. Part 1 Part 2 Part 3 Part 4 Part 5 Part 6 Still […]Read More DigiPharm Europe 2010 Pt 7
So here’s the penultimate part of this week-long series. Today I am focusing on the morning session of Day 2 of DigiPharm 2010 and the concluding blog post tomorrow will cover the afternoon session. I will not cover every presentation from Day 2, just the ones that had impact with the audience. Part 1 Part […]Read More DigiPharm Europe 2010 Pt 6
Once more unto the DigiPharm breach. Part 1 Part 2 Part 3 Part 4 Part 6 Part 7 Building up to reportable adverse events When last we spoke, I covered patient community discussions. We now turn our attention to reportable adverse events and the Internet presented by Daniel Ghinn and Paul Grant. They start by […]Read More DigiPharm Europe 2010 Pt 5